Elevance Health, Inc.
ELV
$342.93
-$5.25-1.51%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 30.86% | 17.03% | -24.22% | -2.80% | -51.17% |
| Total Depreciation and Amortization | -18.15% | 17.63% | 13.43% | 12.69% | -28.74% |
| Total Amortization of Deferred Charges | 9.40% | -- | -- | -- | 7.15% |
| Total Other Non-Cash Items | -275.00% | 243.33% | 163.95% | -36.76% | -187.62% |
| Change in Net Operating Assets | -2,811.11% | -160.39% | 88.85% | -80.67% | 99.59% |
| Cash from Operations | -88.10% | -57.60% | 359.51% | -48.58% | 123.76% |
| Capital Expenditure | 9.01% | -8.43% | 17.34% | 29.75% | 1.23% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.90% | -- | -- | -- | -20,572.22% |
| Divestitures | -- | -- | -87.47% | -- | -- |
| Other Investing Activities | -69.90% | -1,153.62% | 47.19% | 132.38% | 433.56% |
| Cash from Investing | 128.33% | -205.24% | 16.01% | 104.46% | -59.18% |
| Total Debt Issued | -69.09% | 7,275.00% | -80.49% | -46.48% | 1,385.84% |
| Total Debt Repaid | 62.65% | -264.44% | 2.80% | -132.94% | -390.78% |
| Issuance of Common Stock | 262.50% | -100.00% | -- | -76.29% | -60.00% |
| Repurchase of Common Stock | 73.98% | -1,213.64% | 35.85% | -50.60% | -95.47% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.07% | -0.79% | -1.85% | -1.85% | -7.80% |
| Other Financing Activities | 271.43% | 2,000.00% | -25.00% | -450.00% | -450.00% |
| Cash from Financing | -83.24% | 126.56% | -146.11% | -6,065.63% | 457.36% |
| Foreign Exchange rate Adjustments | 25.00% | -114.29% | 120.00% | -- | -900.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 84.36% | -88.82% | 291.14% | -162.67% | 109.61% |